12-19440002-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2
The NM_153207.5(AEBP2):āc.303G>Cā(p.Glu101Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000302 in 1,525,390 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_153207.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AEBP2 | NM_153207.5 | c.303G>C | p.Glu101Asp | missense_variant | 1/8 | ENST00000266508.14 | NP_694939.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AEBP2 | ENST00000266508.14 | c.303G>C | p.Glu101Asp | missense_variant | 1/8 | 1 | NM_153207.5 | ENSP00000266508 | ||
AEBP2 | ENST00000398864.7 | c.303G>C | p.Glu101Asp | missense_variant | 1/9 | 1 | ENSP00000381840 | P1 | ||
AEBP2 | ENST00000538425.5 | c.-16-22508G>C | intron_variant | 4 | ENSP00000444255 | |||||
AEBP2 | ENST00000541908.5 | c.-16-22508G>C | intron_variant | 3 | ENSP00000437983 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152046Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000320 AC: 4AN: 124834Hom.: 0 AF XY: 0.0000295 AC XY: 2AN XY: 67818
GnomAD4 exome AF: 0.0000211 AC: 29AN: 1373344Hom.: 0 Cov.: 35 AF XY: 0.0000251 AC XY: 17AN XY: 677954
GnomAD4 genome AF: 0.000112 AC: 17AN: 152046Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74280
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at